Results

Total Results: 2,260 records

Showing results for "compared".

  1. effectivehealthcare.ahrq.gov/sites/default/files/considerations-for-statistical-chapter-10.pptx
    January 01, 2013 - Covariate Selection for Observational Comparative Effectiveness Research Considerations for Statistical Analysis in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Considerations for Statistical Analysis in Observational Comparative Effe…
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-other-plant-based-treatments-evidence-summary_0.pdf
    October 01, 2021 - Key Question 1: Benefits of cannabinoids for chronic pain compared with placebo in the short term (4 … Key Question 2: Harms of cannabinoids for chronic pain compared with placebo in the short term (4 weeks … sprays, with large increased risk of dizziness and sedation, and moderate increased risk of nausea compared … due to adverse events, serious adverse events, and sedation, and a large increased risk of dizziness compared
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
    August 01, 2022 - Metoclopramide No study in the original report compared these interventions, but in general, compared … with placebo or lasmiditan 200 mg compared with lasmiditan 100 mg. … MAGraine: magnesium compared to conventional therapy for treatment of migraines. … MAGraine: magnesium compared to conventional therapy for treatment of migraines. … ACHIEVE II trial: Ubrogepant compared to placebo for migraine attacks. [German].
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_disposition-comments.pdf
    July 01, 2012 - report differs from these other guidelines and how this report should be used by readers/clinicians [compared … Peer Reviewer 4 Results 2) Page 18 line 18: “Relatively few studies compared CPAP to supportive care … Relatively few studies compared any mode of NPPV to invasive ventilation or to conventional weaning
  5. effectivehealthcare.ahrq.gov/sites/default/files/outcome-definition-and-measurement-chapter-6.pptx
    January 01, 2013 - The study power for a given sample size may be increased when such composite measures are used as compared … bias; e.g., when liver function testing is preferentially performed in patients using a new drug being compared
  6. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cervical-degenerative-protocol.pdf
    January 12, 2022 - one systematic review4 found the prevalence of multilevel degenerative disc pathology to be 64.5% (compared … This review will include nonoperative management of cervical degenerative disease as compared with operative … the comparative effectiveness and harms of therapies added on to surgery (pre- or post-operative) compared … cervical fusion surgery, what are the comparative effectiveness and harms of posterior approaches compared … Efficacy and safety of total disc replacement compared with anterior cervical discectomy and fusion
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/major-depressive-disorder_consumer.pdf
    September 01, 2016 - Researchers looked at 44 studies that compared antidepressants with other treatments for depression. … When researchers compared it with antidepressants as a first treatment for depression, they found: … The chart below lists three types of talk therapy that researchers compared with antidepressants.
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0715-140408.pdf
    May 29, 2025 - What is the comparative safety and effectiveness of beta-blockers to treat infantile hemangioma as compared
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/disposition-of-comments-cer-192-anxiety-in-children.pdf
    August 31, 2017 - to autism), when it was provided in school setting (compared to outpatient or mental health settings … TEP 1 Introduction p. 6 lines 37-40 “compared to placebo” is repeated at the beginning and end … The studies compared CBT to CBT and medications. … This is akin to early meta-analyses of psychotherapy that compared categories such as “verbal” and … P.15, line 41 in second bullet point: replace “compared” with “more than” 10.
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
    June 01, 2022 - Placebo From the previous report, NSAIDs as a drug class, compared with placebo, resolved pain at … with placebo or lasmiditan 200 mg compared with lasmiditan 100 mg. … with placebo or lasmiditan 200 mg was compared with lasmiditan 100 mg. … against active treatment) Triptans (if compared against active treatment) Ergot alkaloids Combination … RDC Clinical Pty Ltd A study evaluating the effectiveness of PEA compared to placebo for reducing pain
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-web-interactive-presentation.pdf
    September 01, 2019 - We added no new information in the tool compared to the contents of the EPC report. … Edges connect a pair of nodes only if the corresponding interventions have been compared in at least … interventions and intervention categories; whether there are groups of interventions that have been compared … between them but not with other groups of interventions; how many and which studies have compared various … For example, the part of the tool that describes which treatments have been compared between them and
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_disposition-comments.pdf
    May 08, 2013 - Although there were no substantial new findings compared to the systematic review by Reddy et al in … We have revised the text to clarify what is compared in each study. … to gauze at 8, 10 and 12 weeks, with 51% of gauze-dressed subjects healed at 12 weeks compared to … with foam surfaces (three of four studies), or with LAL beds compared with LAL overlays" (Table … We have added a comment to our Discussion section about the expanded scope of our review compared to
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/epc-synthesizing-evidence-improve.pdf
    July 01, 2020 - qualities of medical tests necessitate a different or variation of the approach to systematic review compared
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-adhd-prescription-rapid-research.pdf
    July 01, 2025 - methylphenidate misuse was 0.3 percent in all US adults and 1.2 percent among those aged 19 to 30 compared … having the most severe outcomes, including a 21.9-fold increased risk of mortality compared to controls … As compared to the reference group (Given by Friend), those who misused their own prescription medication … Mode of administration: NR Health: NR Psychological: Compared to those who never used Rx stimulants … : Study compared young adults who were prescribed ADHD stimulants with siblings who were prescribed
  15. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_executive.pdf
    December 01, 2011 - Eight trials directly compared any non-SSRI second-generation antidepressant with any other; of these … The number needed to treat (NNT) to gain 1 additional responder at week 8 with escitalopram compared … A fair-quality effectiveness study provides mixed evidence on the effectiveness of paroxetine compared … The study showed no statistically significant differences in depressive outcomes for fluoxetine compared … Six studies provided mixed evidence for the superiority of duloxetine or paroxetine compared with placebo
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-future_research.pdf
    October 26, 2012 - Immunoassays for toxins A and B: Ten studies directly compared at least 2 immunoassays for toxins A … There were no statistical differences between the sensitivities of immunoassays that were compared; … Gene detection tests versus immunoassays for toxins A and B: Four studies compared at least one toxin … Data on desired outcomes are compared. … Desired outcomes between intervention and comparison groups are compared.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/disabilities-quality-improvement-outcomes_disposition-comments.pdf
    October 15, 2012 - Al.) and particularly patients with disabilities when compared to the clinicians who care for them … inclusion of the complexity of a condition and still allow use of generic outcome measures that could be compared
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-testing-machine-learning-tool-chronic-pain.pdf
    November 01, 2020 - We then qualitatively compared performance from the initial modeling phase (i.e., 2017 citations) to … The search yield (number of citations identified) was higher for the September/October updates compared … Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of … Duloxetine compared with pregabalin for diabetic peripheral neuropathic pain management in patients … Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the
  19. effectivehealthcare.ahrq.gov/sites/default/files/nt_docs/topic-brief-updating-pharmacotherapy.pdf
    September 30, 2022 - One 2018 Cochrane review3 included 11 studies assessing the effectiveness of Baclofen compared to placebo … Another 2020 systematic review5 compared the adverse effects associated with Citalopram, Fluoxetine, … conducted in a primary care setting, examining the effectiveness and safety of high-dose Baclofen compared … Another 2020 systematic review5 compared the effectiveness of approximately 20 different pharmacologic … One study also examined the effectiveness of Olanzapine monotherapy compared to combined Olanzapine
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
    January 24, 2022 - 33835707 Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared … of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared … of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared … ) 10,457 748 9,709 5 743 830 8,879 The protective effect conferred by previous infection, added and compared … The prevalence of infections classified as symptomatic or asymptomatic was compared for primary infections

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: